Effect of tezepelumab on healthcare utilization in patients with severe, uncontrolled asthma: The NAVIGATOR study.

Menzies-Gow, Andrew; Bourdin, Arnaud; Chupp, Geoffrey; Israel, Elliot; Hellqvist, Åsa; Hunter, Gillian; Roseti, Stephanie L; Ambrose, Christopher S; Llanos, Jean-Pierre; Cook, Bill; Corren, Jonathan; Colice, Gene

Menzies-Gow, Andrew; Bourdin, Arnaud; Chupp, Geoffrey; Israel, Elliot; Hellqvist, Åsa; Hunter, Gillian; Roseti, Stephanie L; Ambrose, Christopher S; Llanos, Jean-Pierre; Cook, Bill; Corren, Jonathan; Colice, Gene.

Afiliación

Menzies-Gow A; Royal Brompton and Harefield Hospitals, School of Immunology & Microbial Sciences, King's College, London, United Kingdom. Electronic address: a.menzies-gow@rbht.nhs.uk.
Bourdin A; PhyMedExp, University of Montpellier, CNRS, INSERM, CHU Montpellier, Montpellier, France.
Chupp G; Yale School of Medicine, New Haven, Connecticut.
Israel E; Pulmonary and Critical Care Medicine, Allergy & Immunology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Hellqvist Å; Biometrics, Late-stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Hunter G; Biometrics, Late-stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.
Roseti SL; Late-stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland.
Ambrose CS; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, Maryland.
Llanos JP; Global Medical Affairs, Amgen, Thousand Oaks, California.
Cook B; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, Maryland.
Corren J; David Geffen School of Medicine, UCLA, Los Angeles, California.
Colice G; Late-stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland.

Ann Allergy Asthma Immunol ; 131(3): 343-348.e2, 2023 09.

Article en En | MEDLINE | ID: mdl-37263380

Asunto(s)

Antiasmáticos; Asma; Humanos; Calidad de Vida; Aceptación de la Atención de Salud; Método Doble Ciego

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Asma / Antiasmáticos Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Ann Allergy Asthma Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google